SAN CARLOS, Calif.--(BUSINESS WIRE)--NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and labeling systems announced today that it has received US Patent No. 7,402,386, “Global amplification using random priming by a composite primer.”
